Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostaglandin analogs for preventing progression of diabetic nephropathy
ChiCTR2000040170Phase 4Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Vasostenoon in diabetic glomerulosclerosis (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Renal failure composite endpoint. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
Vasostenoon
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR2000040170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040170.